Download PDF
1 / Pages

Other users also viewed these articles

The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry Jakub Gregor; Yochai Adir; Martina ¿terclová; Nesrin Mogulkoc; Mordechai R. Kramer; Martina Doubková; Martina Pla¿ková; Veronika Müller; Michael Studnicka; Monika ¿urková; Ladislav Lacina; Katarzyna Lewandowska; Vladimír Barto¿; Petra Ovesná; Ond¿ej Májek; Martina Koziar Va¿áková;
Arch Bronconeumol. 2024;60:80-7
Pathophysiology of Chronic Bronchial Infection in Bronchiectasis Belén Solarat; Lidia Perea; Rosa Faner; David de La Rosa; Miguel Ángel Martínez-García; Oriol Sibila;
Arch Bronconeumol. 2023;59:101-8
Latin American Registry of Idiopathic Pulmonary Fibrosis (REFIPI): Clinical Characteristics, Evolution and Treatment Fabián Caro; Ivette Buendía-Roldán; Lorena Noriega-Aguirre; María L. Alberti; Alexandre Amaral; Guillermo Arbo; Santiago Auteri; Aníbal Bermúdez; Pablo Curbelo; Manuel de Jesús Díaz Verduzco; Isabel De la Fuente; Juan I. Enghelmayer; Martin Fernández; Matías Florenzano; Fernando Guillen; Ronaldo Kairalla; Yuri Liberato; Carlos Matiz; Mayra Mejía; Viviana Moyano; Alfredo Pachas; Silvia V. Escotorin; Gabriela Tabaj; Esther Tavera; Alvaro Undurraga; Brenda Varela; José Luis Velazquez; Moises Selman;
Arch Bronconeumol. 2022;58:794-801